183 related articles for article (PubMed ID: 16933379)
1. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines.
Wkly Epidemiol Rec; 2006 Aug; 81(34/35):328-30. PubMed ID: 16933379
[No Abstract] [Full Text] [Related]
2. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007.
Wkly Epidemiol Rec; 2007 May; 82(19):164-7. PubMed ID: 17500103
[No Abstract] [Full Text] [Related]
3. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
[No Abstract] [Full Text] [Related]
4. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
5. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines, February 2009.
Wkly Epidemiol Rec; 2009 Feb; 84(9):72-6. PubMed ID: 19248289
[No Abstract] [Full Text] [Related]
6. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
[No Abstract] [Full Text] [Related]
7. Antigenic and genetic characteristics of influenza A(H5N1)and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2010 Oct; 85(42):418-24. PubMed ID: 20949701
[No Abstract] [Full Text] [Related]
8. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2009 Oct; 84(41):432-6. PubMed ID: 19817020
[No Abstract] [Full Text] [Related]
9. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
[No Abstract] [Full Text] [Related]
10. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
11. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
[No Abstract] [Full Text] [Related]
12. Pandemic H5N1 influenza vaccine development: an update.
El Sahly HM; Keitel WA
Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
[TBL] [Abstract][Full Text] [Related]
13. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
[TBL] [Abstract][Full Text] [Related]
14. Pre- or post-pandemic influenza vaccine?
Osterhaus AD
Vaccine; 2007 Jun; 25(27):4983-4. PubMed ID: 17555851
[No Abstract] [Full Text] [Related]
15. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
16. Vaccines for a potential influenza pandemic.
Auewarakul P; Thongcharoen P
Future Microbiol; 2007 Jun; 2(3):345-9. PubMed ID: 17661708
[TBL] [Abstract][Full Text] [Related]
17. H5N1 viruses and vaccines.
Subbarao K; Luke C
PLoS Pathog; 2007 Mar; 3(3):e40. PubMed ID: 17335350
[No Abstract] [Full Text] [Related]
18. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
Hasegawa H; Ichinohe T; Tamura S; Kurata T
Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369
[TBL] [Abstract][Full Text] [Related]
19. [Influenza vaccine].
Horimoto T; Murakami S; Kawaoka Y
Nihon Rinsho; 2008 Oct; 66(10):2013-8. PubMed ID: 18939506
[TBL] [Abstract][Full Text] [Related]
20. Influenza and the challenge for immunology.
Doherty PC; Turner SJ; Webby RG; Thomas PG
Nat Immunol; 2006 May; 7(5):449-55. PubMed ID: 16622432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
